Navigation Links
DETRUSAM 500

ProductsDETRUSAM 500
Company INNOVA Medical Ophthalmics
Item DETRUSAM 500
Features 
  • DETRUSAM is developed for use in offices of gynecologists and urologists, obstretical ambulances and relevant hospital departements and enables physicians to heal usually
  • Female urinary stress incontinence within 5 sessions ( 1 session a day/ each 15 minutes) with a success of over 90%
  • Female mixed urinary incontinence within 7 8 sessions with a success of over 80%
  • Female urge urinary incontincence within 9 10 sessions with a success of over 85%
  • DETRUSAM 500 system applicated by introduced physicians make female and male patients free and returns new quality of life to them.
Description The non medicamental painfree therapy stimulates the spincter and pelvic floor muscles by causing veritable contractions and relaxation. By use of DETRUSAM as a prophylactic step any surgical operations (bladder liftings) may be avoided. After necessary bladder lifting DETRUSAM can improve unsatisfying results. DETRUSAM intravesical Catheter and the first autoclavable vaginal probe URIELLA are worldwide patented.
Info INNOVA Medical Ophthalmics
Customer Service: (800) 461-1200
Web site: http://www.innovamedonline.com/

Related medicine products :

1. Dornier Medilas D Fibertom Endovenous Laser Treatment
2. Essentials of Diagnosis and Treatment 2nd Edition for PDA
3. DeepLight Glaucoma Treatment System
4. Salter AIRE Plus® Portable Treatment Compressor (115V)
5. Salter AIRE Plus® Portable Treatment Compressor (230V) European Model
6. Salter AIRE Plus® Portable Treatment Compressor (230V) United Kingdom Model
7. TRIVEX™ System Varicose Vein Treatment
8. Precision 980 Vein Laser -
VenaCure Laser Vein Treatment

9. Pocket Guide to Colorectal Cancer Drugs and Treatment
10. Essentials of Diagnosis & Treatment in Surgery
11. Essentials of Diagnosis & Treatment in Cardiology
Jewelers Forceps, delicate, straight....
2 mm wide tip with 1 mm by 4 mm eye. Curved shaft and ring handle with polished finish....
Straight iris forceps. Insulated....
Hardy bayonet forceps with stops. Insulated....
Medicine Products:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: